Topline data were announced from a phase 3 trial evaluating somapacitan in children born small for gestational age, with Noonan syndrome, or with idiopathic short stature.

The work tests and revises a 50-year old textbook model, known as the Bloch hypothesis, for the evolution of sterol metabolism in eukaryotic cells. The results indicate that the complexity of sterol ...